CLINICAL CHARACTERISTICS OF METABOLIC SYNDROME IN COMBINATION WITH THYROID DYSFUNCTION.
Keywords:
Metabolic syndrome, thyroid glandAbstract
Diabetes mellitus (DM) and cardiovascular diseases (CVD), along with cancer and chronic respiratory diseases, are the most formidable “killers” in the world and cause approximately 35 million deaths per year [World Health Organization, 2018]. Metabolic syndrome (MS) is the basis for the development of non-insulin-dependent diabetes (NIDDM), as well as CVD [Simmons R. et al., 2010; Alexandrov O.V. et al., 2016; Holvoet P, 2018; Van Zwieten P.A., Mancia G., 2015].
References
Ford ES, Giles WH. A comparison of the
prevalence of the metabolic syndrome using
two proposed definitions. Diabetes Care. 2003;
(3): 575-581. doi: 10.2337/diacare.26.3.575
2. Panov AV, Dikalov SI, Darenskaya MA,
Rychkova LV, Kolesnikova LI, Kolesnikov SI.
Mitochondria: Aging, metabolic syndrome and
cardiovascular diseases. Formation of a new
paradigm. Acta biomedica scientifica. 2020;
(4): 33-44. (In Russ.). doi: 10.29413/
ABS.2020-5.4.5
3. Gavrila D, Salmerón D, Egea-Caparrós JM,
Huerta JM, Pérez-Martínez A, Navarro C, et al.
Prevalence of metabolic syndrome in Murcia
Region, a southern European Mediterranean
area with low cardiovascular risk and high
obesity. BMC Public Health. 2011; 11: 562.
doi: 10.1186/1471-2458-11-562
4. Belenkaya LV. Criteria of obesity for Asian
population. Literature review. Acta biomedica
scientifica. 2018; 3(3): 99-102. (In Russ.).
doi: 10.29413/ABS.2018-3.3.15
5. Herningtyas EH, Ng TS. Prevalence and
distribution of metabolic syndrome and its
components among provinces and ethnic
groups in Indonesia. BMC Public Health. 2019;
(1): 377. doi: 10.1186/s12889-019-6711-7
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
